Growing Menace of Chronic Diseases Escalating Immunotherapy Drug Sales

Chronic diseases, such as cancer and rheumatoid arthritis, which require immunotherapy drugs for treatment or management, are rising in prevalence. This is why the domain for such drugs is progressing across the world. Download Report Sample at: https://www.psmarketresearch.com/market-analysis/immunotherapy-drugs-market In a 2018 report, the World Health Organization estimated the worldwide death toll due to cancer that year to be 9.6 million! The rise in the number of deaths due to such chronic diseases is expected to drive the sales of immunotherapy drugs across the world during the forecast period. Another reason behind the growth of the domain is the development and easy availability of monoclonal antibodies (mAb). Advantages such as high sensitivity toward salt concentration and pH change and high and pure concentration compared to polyclonal antibodies are leading to the development of mAb-containing immunotherapy drugs, which is predicted to drive the domain further.